Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Plews, Jordan R ^a,b   Li, JianLiang ^a   Jones, Mark ^a   Moore, Harry D ^a   Mason, Chris ^b   Andrews, Peter W ^a   Na, Jie ^a,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALKALINE PHOSPHATASE; CARRIER PROTEIN; DNA METHYLTRANSFERASE 3B; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; METHYLTRANSFERASE INHIBITOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN SALL4; REX PROTEIN; REX PROTEIN 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VALPROIC ACID; VIRUS LARGE T ANTIGEN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL FATE; CELL NUCLEUS; CELL PROLIFERATION; CELL REPROGRAMMING; CELL SURVIVAL; CONTROLLED STUDY; ELECTROPORATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; FETUS; GENE ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN FIBROBLAST; BIOLOGICAL MODEL; CULTURE TECHNIQUE; CYTOLOGY; FIBROBLAST; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR CLONING; NUCLEAR REPROGRAMMING; POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE;

IPS;

ALKALINE PHOSPHATASE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL NUCLEUS; CLONING, MOLECULAR; FIBROBLASTS; GENETIC TECHNIQUES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, GENETIC; NUCLEAR REPROGRAMMING; POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 78651254192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014397     Document Type: Article

References (45)

1. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, et al. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775.
2. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, et al. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
3. Zhou H, Wu S, Joo JY, Zhu S, Han DW, et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.
4. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
5. Desponts C, Ding S (2010) Using small molecules to improve generation of induced pluripotent stem cells from somatic cells. Methods Mol Biol 636: 207-218.
6. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, et al. (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142: 375-386.
7. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, et al. (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature.
8. Wiehe JM, Ponsaerts P, Rojewski MT, Homann JM, Greiner J, et al. (2007) mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression. J Cell Mol Med 11: 521-530.
9. Smits E, Ponsaerts P, Lenjou M, Nijs G, Van Bockstaele DR, et al. (2004) RNAbased gene transfer for adult stem cells and T cells. Leukemia 18: 1898-1902.
10. Lee J, Dollins CM, Boczkowski D, Sullenger BA, Nair S (2008) Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigenspecific T-cell responses. Immunology 125: 229-240.
11. Boczkowski D, Lee J, Pruitt S, Nair S (2009) Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy. Cancer Gene Ther 16: 900-911.
12. Melhem NM, Liu XD, Boczkowski D, Gilboa E, Barratt-Boyes SM (2007) Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag. Eur J Immunol 37: 2164-2173.
13. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, et al. (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321: 699-702.
14. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, et al. (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227: 271-278.
15. Lemaire P, Garrett N, Gurdon JB (1995) Expression cloning of Siamois, a Xenopus homeobox gene expressed in dorsal-vegetal cells of blastulae and able to induce a complete secondary axis. Cell 81: 85-94.
16. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22: 1567-1572.
17. Papapetrou EP, Tomishima MJ, Chambers SM, Mica Y, Reed E, et al. (2009) Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A 106: 12759-12764.
18. Mali P, Ye Z, Hommond HH, Yu X, Lin J, et al. (2008) Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts. Stem Cells.
19. Zhao Y, Yin X, Qin H, Zhu F, Liu H, et al. (2008) Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3: 475-479.
20. Banito A, Rashid ST, Acosta JC, Li S, Pereira CF, et al. (2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 23: 2134-2139.
21. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, et al. (2009) Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460: 1145-1148.
22. Li H, Collado M, Villasante A, Strati K, Ortega S, et al. (2009) The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460: 1136-1139.
23. Marion RM, Strati K, Li H, Murga M, Blanco R, et al. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460: 1149-1153.
24. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, et al. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460: 1132-1135.
25. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144.
26. Egli D, Rosains J, Birkhoff G, Eggan K (2007) Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature 447: 679-685.
27. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, et al. (2009) Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature.
28. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, et al. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797.
29. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, et al. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol.
30. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, et al. (2008) A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2: 525-528.
31. Glover AB, Leyland-Jones B (1987) Biochemistry of azacitidine: a review. Cancer Treat Rep 71: 959-964.
32. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395: 89-93.
33. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
34. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
35. Ma DK, Chiang CH, Ponnusamy K, Ming GL, Song H (2008) G9a and Jhdm2a Regulate Embryonic Stem Cell Fusion-Induced Reprogramming of Adult Neural Stem Cells. Stem Cells.
36. Yu J, Vodyanik MA, He P, Slukvin, II, Thomson JA (2006) Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 24: 168-176.
37. Pereira CF, Terranova R, Ryan NK, Santos J, Morris KJ, et al. (2008) Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet 4: e1000170.
38. Wong CC, Gaspar-Maia A, Ramalho-Santos M, Reijo Pera RA (2008) Highefficiency stem cell fusion-mediated assay reveals Sall4 as an enhancer of reprogramming. PLoS One 3: e1955.
39. Hochedlinger K, Jaenisch R (2002) Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415: 1035-1038.
40. Kocabas AM, Crosby J, Ross PJ, Otu HH, Beyhan Z, et al. (2006) The transcriptome of human oocytes. Proc Natl Acad Sci U S A 103: 14027-14032.
41. Cheng J, DeCaprio JA, Fluck MM, Schaffhausen BS (2009) Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens. Semin Cancer Biol 19: 218-228.
42. Yakubov E, Rechavi G, Rozenblatt S, Givol D (2010) Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun 394: 189-193.
43. Angel M, Yanik MF (2010) Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 5: e11756.
44. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455: 627-632.
45. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630.